(Frankfort, KY) — The Pharmaceutical Care Management Association (PCMA) released the following statement on the passage of House Bill 220 in Kentucky. “PCMA applauds the legislature in Kentucky and Governor Beshear on the passage of HB 220, which expands on
Study Finds Yearly Cost of Patent Thickets on Five Top-Selling Brand Name Drugs Ranges from $1.8 to $7.6 Billion In case you missed it, a new report from The Coalition for Affordable Prescription Drugs (CAPD) and conducted by Matrix Global
PCMA Policy Platform Prioritizes Patients with Solutions to Promote Competition, Lower Drug Costs, Support Better Health Outcomes & Maximize the Value of Pharmacy Benefits (Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released today a new policy platform, “Unlocking
Senior Advisor, MedImpact Mr. Marsella is currently a Senior Advisor at MedImpact. He has more than 20 years of experience in healthcare and pharmacy benefit administration and management. He was promoted to Senior Vice President, Sales and Marketing at the
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement on Illinois HB 3479: “Employers, unions, and state health programs hire pharmacy benefit managers (PBMs) to reduce costs for patients by, among other things, negotiating discounts with
(Washington, D.C.) — Today, representative organizations of America’s pharmaceutical supply and payment chain, including prescription and over-the-counter brand and generic manufacturers; wholesalers; retail, specialty, and managed care, pharmacies; health insurance providers and other payers; pharmacists in hospitals and health systems; and
(Washington, D.C.) — The Pharmaceutical Care Management Association released the following statement on Illinois legislation, HB 4146: “This bill would force the state’s employers, unions and others that provide pharmacy benefits to continue covering expensive brand drugs, even when more affordable, equally
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on the Biden Administration’s announcement to curb drug manufacturer patent abuses. “We applaud the Biden Administration for taking real action to reduce prescription
©2024 PCMA. All Rights Reserved.
